• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALERE SAN DIEGO MEDLINE HCG COMBO CASSETTE; HCG PREGNANCY TEST.

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALERE SAN DIEGO MEDLINE HCG COMBO CASSETTE; HCG PREGNANCY TEST. Back to Search Results
Model Number FHC-A202
Device Problem False Negative Result (1225)
Patient Problem Insufficient Information (4580)
Event Type  malfunction  
Manufacturer Narrative
Results pending completion of the investigation.
 
Event Description
It was reported that false negatives were occurring with no confirmatory information.Although requested, no further information has been provided.There was no adverse event nor injuries reported.
 
Manufacturer Narrative
D9: no.H3: not returned to the manufacturer.Investigation conclusion: retained devices from the reported lot number were tested with qc cut-off urine standards 20 miu/ml) and high-hcg clinical urine samples (212.0-215.6 iu/ml).The results were read at 3 minutes and all devices yielded the expected positive results.Retained devices were also tested with qc cut-off serum standards (10 miu/ml).The results were read at 5 minutes and all devices yielded the expected positive results.No false negative results were observed during in-house testing.The case details were reviewed along with the complaint history for the reported issue and no indications of a systemic issue were identified.Manufacturing batch record review did not uncover any relevant non-conformances and found that the lot met quality control specifications.Review of the risk management report for this product found that the reported issue is within the risk profile for this device; no new hazard has been identified.A root cause could not be determined from the available information as the reported issue was not replicated during testing of retention product.Complaints are tracked and trended on a monthly basis.Per the package insert, false negative results may occur when the levels of hcg are below the sensitivity level of the test.Very dilute urine specimens, as indicated by a low specific gravity, may not contain representative levels of hcg.If pregnancy is still suspected, a first morning urine specimen should be collected 48 hours later and tested.This test provides a presumptive diagnosis for pregnancy.A confirmed diagnosis should only be made by a physician after all clinical and laboratory findings have been evaluated.
 
Manufacturer Narrative
D9: device available for evaluation.Yes.(b)(6) 2021.H3: yes.Investigation conclusion: retained and returned devices from the reported lot number were tested with qc cut-off urine standards (20 miu/ml) and high-hcg clinical urine samples (205.7-222.1 iu/ml).The results were read at 3 minutes and all devices yielded the expected positive results.Retained devices were also tested with qc cut-off serum standards (10 miu/ml).The results were read at 5 minutes and all devices yielded the expected positive results.No false negative results were observed during in-house testing.The case details were reviewed along with the complaint history for the reported issue and no indications of a systemic issue were identified.Manufacturing batch record review did not uncover any relevant non-conformances and found that the lot met quality control specifications.Review of the risk management report for this product found that the reported issue is within the risk profile for this device; no new hazard has been identified.A root cause could not be determined from the available information as the reported issue was not replicated during testing of either retention or returned product.Complaints are tracked and trended on a monthly basis.Per the package insert, false negative results may occur when the levels of hcg are below the sensitivity level of the test.Very dilute urine specimens, as indicated by a low specific gravity, may not contain representative levels of hcg.If pregnancy is still suspected, a first morning urine specimen should be collected 48 hours later and tested.This test provides a presumptive diagnosis for pregnancy.A confirmed diagnosis should only be made by a physician after all clinical and laboratory findings have been evaluated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MEDLINE HCG COMBO CASSETTE
Type of Device
HCG PREGNANCY TEST.
Manufacturer (Section D)
ALERE SAN DIEGO
9975 summers ridge rd
san diego CA 92121
MDR Report Key11013674
MDR Text Key246835902
Report Number2027969-2020-00090
Device Sequence Number1
Product Code JHI
UDI-Device Identifier30884389191884
UDI-Public(01)30884389191884(17)220331(10)HCG0032114
Combination Product (y/n)N
PMA/PMN Number
K062361
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,health profession
Type of Report Initial,Followup,Followup
Report Date 04/21/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/31/2022
Device Model NumberFHC-A202
Device Lot NumberHCG0032114
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/13/2021
Initial Date Manufacturer Received 04/19/2021
Initial Date FDA Received12/15/2020
Supplement Dates Manufacturer Received12/29/2020
04/19/2021
Supplement Dates FDA Received12/29/2020
04/22/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-